# Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic

> **NCT04668469** · NA · COMPLETED · sponsor: **Benha University** · enrollment: 600 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Ivermectin
- **DRUG:** Hydroxychloroquine
- **BEHAVIORAL:** personal protective Measures

## Key facts

- **NCT ID:** NCT04668469
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-08
- **Primary completion:** 2020-09-15
- **Final completion:** 2020-10-30
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2020-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04668469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04668469, "Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04668469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*